UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS

Show other versions (1)

<p>Follicular lymphoma (FL) remains incurable despite advances in new strategies of treatment, including monoclonal antibodies (MoAb). Except for early stages, FL is characterized by responses to treatments and systematic relapses. The main objective in this disease is to achieve a bet...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mónica Cabrero, Alba Redondo, Alejandro Martin, Dolores Caballero
Format:	Article
Language:	English
Published:	PAGEPress Publications 2012-01-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Online Access:	http://www.mjhid.org/article/view/11091
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS
by: Mónica Cabrero, et al.
Published: (2012-11-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Cryopreservation of Hematopoietic Stem Cells for Pediatric Autologous Stem Cell Transplantation
by: Rasika Dhawan Setia, et al.
Published: (2024-11-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
by: Giuseppe Visani, et al.
Published: (2012-11-01)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01)

EAM conditioning regimen followed by autologous hematopoietic Stem Cell Transplantation for relapsed, refractory and high risk lymphomas
by: Mohamed BEKADJA, et al.
Published: (2014-08-01)

Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation
by: Benjamin Beland, et al.
Published: (2025-01-01)

SURVIVAL OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS
by: Elif Yıldız, et al.
Published: (2024-12-01)

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)

Melphalan Culprit or Confounder in Acute Encephalopathy during Autologous Hematopoietic Stem Cell Transplantation?
by: Diógenes Alayón-Laguer, et al.
Published: (2012-01-01)

ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Angelo Michele Carella
Published: (2012-10-01)

Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas
by: Luis F. Porrata, et al.
Published: (2010-01-01)

UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01)

Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma
by: Kaili Chen, et al.
Published: (2025-01-01)

Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series
by: Alice Mariottini, et al.
Published: (2024-11-01)

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
by: Adrian Schmidt
Published: (2020-11-01)

Time to progression predicts outcome of patients with multiple myeloma that can be influenced by autologous hematopoietic stem cell transplantation
by: Yanhua Yue, et al.
Published: (2025-12-01)

Tandem autologous hematopoietic stem cell transplantation for patients with multiple myeloma: a systematic review and meta-analysis
by: Hongtao Li, et al.
Published: (2024-12-01)

Hematopoietic stem cell transplantation to improve prognosis in aggressive monomorphic epitheliotropic intestinal T-cell lymphoma
by: Gi-June Min, et al.
Published: (2024-11-01)

Pretransplant hypoalbuminemia may be associated with poor survival in patients that underwent autologous hematopoietic stem cell transplantation (autoHSCT)
by: Serdar Sivgin, et al.
Published: (2014-08-01)

Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)
by: Serdar Sivgin
Published: (2013-01-01)

EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
by: Pellegrino Musto, et al.
Published: (2024-08-01)

Autologous hematopoietic stem cell transplant in pediatric solid tumours in India: A single centre experience of 15 years
by: Debabrata Mohapatra, et al.
Published: (2024-01-01)

Autologous hematopoietic stem cell transplant in pediatric solid tumours in India: A single centre experience of 15 years
by: Debabrata Mohapatra, et al.
Published: (2024-01-01)

Histomorphometric Evaluation of Superovulation Effect on Follicular Development after Autologous Ovarian Transplantation in Mice
by: Amin Tamadon, et al.
Published: (2015-01-01)

Predictive factors for engraftment kinetics of autologous hematopoietic stem cells in children
by: Biljana Andrić, et al.
Published: (2024-12-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Rafael de la Camara
Published: (2016-06-01)

PRESENTATION OF 4 CASES OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER HIGH-DOSE CHEMOTHERAPY WITH REFRACTORY SOLID TUMOR DIAGNOSIS
by: Muhammed Murati, et al.
Published: (2024-12-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Comparison of autologous hematopoietic cell transplantation, matched sibling donor hematopoietic cell transplantation, and chemotherapy in patients with favorable- and intermediate-risk acute myeloid leukemia
by: Mingyang Wang, et al.
Published: (2025-01-01)

PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Isidro Jarque, et al.
Published: (2016-07-01)

Hematopoietic stem cell transplantation in systemic sclerosis
by: K G Chengappa, et al.
Published: (2017-01-01)

TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
by: Silvia F Costa, et al.
Published: (2013-11-01)

COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
by: Sanjeev Kumar Sharma, et al.
Published: (2014-06-01)

LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
by: Andrea Riccardo Filippi
Published: (2016-09-01)

Against the odds: Managing pediatric relapsed/refractory Hodgkin lymphoma with autologous stem cell transplant in resource-limited settings
by: Sanjana Sarangarajan, et al.
Published: (2024-01-01)

The role of autologous bone marrow transplantation in primary effusion lymphoma: a case report and literature review
by: Vitor Abreu de Goes, et al.
Published: (2024-12-01)